Cart
sales@molnova.com
PCLX-001
CAS No. 1215011-08-7
PCLX-001( —— )
Catalog No. M35742 CAS No. 1215011-08-7
PCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 348 | In Stock |
|
| 5MG | 549 | In Stock |
|
| 10MG | 755 | In Stock |
|
| 25MG | 1168 | In Stock |
|
| 50MG | 1555 | In Stock |
|
| 100MG | 2061 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePCLX-001
-
NoteResearch use only, not for human use.
-
Brief DescriptionPCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively.
-
DescriptionPCLX-001 is an orally acitve, small-molecule, dual N-myristoyltransferase (NMT) inhibitor, with IC50s of 5 nM (NMT1) and 8 nM (NMT2), respectively. PCLX-001 exhibits anti-tumor activity and inhibits early B-cell receptor (BCR) signaling, can be used to B-cell malignancies research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1215011-08-7
-
Formula Weight537.51
-
Molecular FormulaC24H30Cl2N6O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (18.60 mM; Ultrasonic (<60°C)
-
SMILESN(S(=O)(=O)C1=C(Cl)C=C(C=C1Cl)C=2C=C(N=CC2)N3CCNCC3)C=4C(CC(C)C)=NN(C)C4C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Michael Weickert, et al. Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies. Blood. 2019. 134(s1):3362.
molnova catalog
related products
-
1-(4-Carbethoxypheny...
1-(4-Carbethoxyphenyl)-piperazin is a chemical compound.
-
Albizziin
Albizziin is a glutamase inhibitor and is a glutaminyl-tRNA synthetase inhibitor.
-
Juncusol
Juncusol shows anxiolytic and sedative activities, it shows anxiolytic activity at dosages of 10 mg/kg; it can induce caspase-3-mediated cytotoxicity in HT22 cells. Juncusol has anti-microbial activity, it shows significant activity against MRSA strains.
